TPM1 and neoplasm: miR-21 is one of the most highly expressed miRNAs in PDAC and acts as an oncomiR by repressing genes with tumor suppressor functions such as PTEN, PDCD4, and TPM1, thus enhancing tumor growth and gemcitabine resistance, and, therefore, is a potential diagnostic and therapeutic target [7,8,10].